New hope for cancer pain: experimental drug aims to reduce opioid needs
Symptom relief
Not yet recruiting
This study is testing whether a new drug called 3D1002 can help reduce moderate to severe cancer pain, either alone or when combined with the opioid medication oxycodone. Researchers want to see if this combination provides better pain relief while potentially allowing patients t…
Phase: PHASE2 • Sponsor: 3D Medicines • Aim: Symptom relief
Last updated Mar 23, 2026 15:29 UTC